VMT Scientific Inc. Announces Its Globally Patented Breakthrough VasCir(TM) Technology
November 02 2005 - 6:00AM
PR Newswire (US)
LAS VEGAS, Nov. 2 /PRNewswire-FirstCall/ -- VMT Scientific Inc.
(OTC:VMTF) announces its globally patented breakthrough technology
that may make the need for Peripheral Vascular Disease (PVD) and
Diabetic associated amputations obsolete. Its technology, the
VasCir(TM) system is designed to re-establish microvascularization
and Tissue Histogenesis. Engineering and the Science: VMT
Scientific Inc. has patented a unique design of sophisticated
negative pressure technology that leads to the first controlled and
repeatable method of soft tissue histogenesis. The technology also
has identified several additional unique medical applications and
is protected both domestically and internationally by patents. The
patented methodology and technology is focused on the values
perceived in the areas of neurology, vascular disease, pediatric
medicine and reconstructive/aesthetic medicine. VMT Scientific Inc.
is focused to mature this technology through additional objective
evidence with clinical trials. The clinical data will be used to
file for clearance with the FDA for the therapeutical treatment of
"Diabetic Neuropathy and PVD." Upon clearance, VMT Scientific Inc.
will make available license rights of the VasCir(TM) to
manufacturers and distribution organizations worldwide. The
Technological FACTS are: * Tissue histogenesis is well known and
documented. * The independent production of new tissue is produced
through proper stimulation and the benefits have been shown to last
for years. * Damaged tissues respond with accentuated healing
capabilities. * The VasCir(TM) system has demonstrated its ability
to "non-invasively" control blood flow with increases up to 300%. *
DYNAMICALY controlled increases in blood flow have a dramatic
immune system response. * DYNAMICALY controlled increases in blood
flow to areas previously ischemic facilitates the regeneration of
neurological tissues. Please visit VMT Scientific, Inc.'s Web site
for more information: http://www.vmtf.com/ This Press Release
contains forward-looking statements within the meaning of the "safe
harbor" provisions of the Private Securities Litigation Reform Act
of 1995. You should not place undue reliance on these
forward-looking statements. These statements involve risks and
uncertainties that could cause actual results to differ materially
from those suggested in the forward- looking statements,
particularly those risks and uncertainties inherent in the process
of developing, manufacturing and distributing medical products and
Clinical trials. Factors that may cause such a difference include
risks related to VMT Scientific Inc.'s limited operating history,
risks associated with completing development and obtaining FDA
medical approvals, successful patent protection and prosecution,
successful sale of licensed technology nationally or
internationally. VMT Scientific technology will not meet with
market acceptance, the risk of future warranty and product
liability claims, the uncertainty of VMT Scientific Inc.'s future
access to capital to sustain operations, achieve profitability or
continue as a going concern, the failure by VMT Scientific Inc.'s
to secure and maintain relationships with suppliers, manufacturers
and other third parties, reliance on key employees, and dependence
on intellectual property. World events, national economy and/or
other conditions and circumstances beyond our control. Further
information on the factors and risks that could affect VMT
Scientific Inc.'s business, financial condition and results of
operations. These forward-looking statements are based on
information and management's expectations as of the date hereof.
Future results may differ materially from our current expectations.
VMT Scientific Inc.'s disclaims any intent or obligation to update
whose forward-looking statements. "Saving feet and limbs is what
it's all about" Says VMT Scientific Inc. DATASOURCE: VMT
Scientific, Inc. CONTACT: Catherine S. Ratelle, Director of
Operations, VMT Scientific, Inc., +1-702-990-3477, Web site:
http://www.vmtf.com/
Copyright